Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|October 1, 1983
Investigation of the beta-cyclodextrin-hydrocortisone inclusion compoundS G Frank, D R KavaliunasJournal of Pharmaceutical Sciences|December 1, 1978
Phase solubility analysis and PMR study of complexing behavior of dinoprostone with beta-cyclodextrin in waterS G Frank, M J ChoJournal of Pharmaceutical Sciences|February 1, 1985
Dissolution dialysis studies of metronidazole-montmorillonite adsorbatesR Shrivastava, S R Jain, S G FrankAmerican Journal of Hospital Pharmacy|April 1, 1983
Particulate matter in four reconstituted cephalosporin injectionsD J Kilarski, J A Visconti, S G FrankJournal of Pharmaceutical Sciences|April 1, 1986
Drug release studies on an oil-water emulsion based on a eutectic mixture of lidocaine and prilocaine as the dispersed phaseA A Nyqvist-Mayer, A F Brodin, S G FrankJournal of Pharmaceutical Sciences|November 1, 1985
Phase distribution studies on an oil-water emulsion based on a eutectic mixture of lidocaine and prilocaine as the dispersed phaseA A Nyqvist-Mayer, A F Brodin, S G FrankRetina (Philadelphia, Pa.)|January 1, 1990
Ocular toxicity of vitreal pluronic polyol F-127F H Davidorf, R B Chambers, O W Kwon, et al.Journal of Pharmaceutical Sciences|May 1, 1976
Tritiated naltrexone binding in plasma from several species and tissue distribution in miceT M Ludden, L Malspeis, J D Baggot, et al.Research Communications in Chemical Pathology and Pharmacology|September 1, 1975
Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexolL Malspeis, M S Bathala, T M Ludden, et al.Genes and Immunity|February 22, 2008
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African AmericansJ A Kelly, J M Kelley, K M Kaufman, et al.Pageof 1